5-hydroxytryptamine medications for the treatment of obesity (Q38449992)

3 September 2017

1 reference

title

5-hydroxytryptamine medications for the treatment of obesity (English)

1 reference

3 September 2017

0 references

L K Burke

1

1 reference

3 September 2017

L K Heisler

series ordinal

2

1 reference

3 September 2017

publication date

1 June 2015

1 reference

Journal of Neuroendocrinology

3 September 2017

published in

1 reference

3 September 2017

volume

27

1 reference

3 September 2017

issue

6

1 reference

3 September 2017

page(s)

389-398

1 reference

Global obesity: trends, risk factors and policy implications

3 September 2017

cites work

1 reference

Projecting the future diabetes population size and related costs for the U.S.

21 January 2018

1 reference

Obesity as a clinical and public health problem: is there a need for a new definition based on lipotoxicity effects?

21 January 2018

1 reference

Human genetics illuminates the paths to metabolic disease

21 January 2018

1 reference

The leptin melanocortin pathway and the control of body weight: lessons from human and murine genetics.

21 January 2018

1 reference

New approaches to the pharmacological treatment of obesity: can they break through the efficacy barrier?

21 January 2018

1 reference

Unraveling the brain regulation of appetite: lessons from genetics

21 January 2018

1 reference

From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior

21 January 2018

1 reference

Neurobiology of food intake in health and disease

21 January 2018

1 reference

Pharmacological management of appetite expression in obesity

21 January 2018

1 reference

Brain serotonin system in the coordination of food intake and body weight

21 January 2018

1 reference

Serotonin and the orchestration of energy balance

21 January 2018

1 reference

The biosynthesis of 5-hydroxytryptamine in brain

21 January 2018

1 reference

Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies.

21 January 2018

1 reference

Raphe unit activity in freely moving cats: Correlation with level of behavioral arousal

21 January 2018

1 reference

The human raphe nuclei and the serotonergic system.

21 January 2018

1 reference

Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes

21 January 2018

1 reference

Molecular biology of serotonin receptors structure and function at the molecular level

21 January 2018

1 reference

Pharmacological targeting of the serotonergic system for the treatment of obesity

21 January 2018

1 reference

Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking

21 January 2018

1 reference

Prevention of 5-hydroxytryptamine2C receptor RNA editing and alternate splicing in C57BL/6 mice activates the hypothalamic-pituitary-adrenal axis and alters mood

21 January 2018

1 reference

RNA Editing Induces Variation in Desensitization and Trafficking of 5-Hydroxytryptamine 2c Receptor Isoforms

21 January 2018

1 reference

Molecular biology of 5-HT receptors

21 January 2018

1 reference

Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling

21 January 2018

1 reference

Hyperphagia and Increased Growth in Rats After Intraventricular Injection of 5,7-Dihydroxytryptamine

21 January 2018

1 reference

Hyperphagia and Obesity Following Serotonin Depletion by Intraventricular p -Chlorophenylalanine

21 January 2018

1 reference

Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat.

21 January 2018

1 reference

International trial of long-term dexfenfluramine in obesity.

21 January 2018

1 reference

Dexfenfluramine. An updated review of its therapeutic use in the management of obesity

21 January 2018

1 reference

Valvular heart disease associated with fenfluramine-phentermine

21 January 2018

1 reference

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects

21 January 2018

1 reference

A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents

21 January 2018

1 reference

5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system

21 January 2018

1 reference

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

21 January 2018

1 reference

5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis

21 January 2018

1 reference

Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors

21 January 2018

1 reference

Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia

21 January 2018

1 reference

Serotonin 2C receptor agonists and the behavioural satiety sequence in mice.

21 January 2018

1 reference

Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene

21 January 2018

1 reference

Thermogenic effect of YM348, a novel 5-HT2C-receptor agonist, in rats

21 January 2018

1 reference

Lorcaserin, a 5-HT(2C) receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure

21 January 2018

1 reference

Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study

21 January 2018

1 reference

Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization

21 January 2018

1 reference

A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial

21 January 2018

1 reference

Lorcaserin (APD356), a selective 5-HT(2C) agonist, reduces body weight in obese men and women

21 January 2018

1 reference

Multicenter, placebo-controlled trial of lorcaserin for weight management

21 January 2018

1 reference

Safety and efficacy of lorcaserin: a combined analysis of the BLOOM and BLOSSOM trials

21 January 2018

1 reference

The development of tolerance to drugs that suppress food intake

21 January 2018

1 reference

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

21 January 2018

1 reference

Enhanced aggressive behavior in mice lacking 5-HT1B receptor.

21 January 2018

1 reference

5-HT1B receptor knockout mice show a compensatory reduction in 5-HT2C receptor function.

21 January 2018

1 reference

Male and female 5-HT(1B) receptor knockout mice have higher body weights than wildtypes

21 January 2018

1 reference

Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors

21 January 2018

1 reference

Sumatriptan decreases food intake and increases plasma growth hormone in healthy women.

21 January 2018

1 reference

Molecular, pharmacological and functional diversity of 5-HT receptors

21 January 2018

1 reference

Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task

21 January 2018

1 reference

Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats

21 January 2018

1 reference

A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze.

21 January 2018

1 reference

Reduced sensitivity to diet-induced obesity in mice carrying a mutant 5-HT6 receptor

21 January 2018

1 reference

Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders

21 January 2018

1 reference

Effects of altered 5-ht6 expression in the rat: functional studies using antisense oligonucleotides

21 January 2018

1 reference

Distribution of cells responsive to 5-HT₆ receptor antagonist-induced hypophagia

21 January 2018

1 reference

Role of central melanocortin pathways in energy homeostasis

21 January 2018

1 reference

Central nervous system control of food intake and body weight

21 January 2018

1 reference

5-HT obesity medication efficacy via POMC activation is maintained during aging

21 January 2018

1 reference

A serotonin and melanocortin circuit mediates D-fenfluramine anorexia

21 January 2018

1 reference

Activation of central melanocortin pathways by fenfluramine

21 January 2018

1 reference

5-HT2CRs expressed by pro-opiomelanocortin neurons regulate insulin sensitivity in liver

21 January 2018

1 reference

5-HT2C receptor agonist anorectic efficacy potentiated by 5-HT1B receptor agonist coapplication: an effect mediated via increased proportion of pro-opiomelanocortin neurons activated

21 January 2018

1 reference

Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis

21 January 2018

1 reference

Rapamycin ameliorates age-dependent obesity associated with increased mTOR signaling in hypothalamic POMC neurons

21 January 2018

1 reference

AgRP innervation onto POMC neurons increases with age and is accelerated with chronic high-fat feeding in male mice

21 January 2018

1 reference

Reduced hypophagic effects of d-fenfluramine and the 5-HT2C receptor agonist mCPP in 5-HT1B receptor knockout mice

21 January 2018

1 reference

Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus

21 January 2018

1 reference

Rapid rewiring of arcuate nucleus feeding circuits by leptin.

21 January 2018

1 reference

Divergence of melanocortin pathways in the control of food intake and energy expenditure

21 January 2018

1 reference

Serotonin-induced hypoglycemia and increased serum insulin levels in mice

21 January 2018

1 reference

Acute dexfenfluramine administration normalizes glucose tolerance in rats with insulin-deficient diabetes

21 January 2018

1 reference

Improvement of insulin sensitivity and cardiovascular outcomes in the JCR:LA-cp rat by D-fenfluramine.

21 January 2018

1 reference

Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine.

21 January 2018

1 reference

Fenfluramine increases insulin action in patients with NIDDM.

21 January 2018

1 reference

Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus

21 January 2018

1 reference

Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies

21 January 2018

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways

21 January 2018

1 reference

Central melanocortin receptors regulate insulin action

21 January 2018

1 reference

Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene

21 January 2018

1 reference

Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis

21 January 2018

1 reference

Melanocortin 4 receptors in autonomic neurons regulate thermogenesis and glycemia

21 January 2018

1 reference

Effects of neonatal removal of superior cervical ganglion on serotonin and thyrotropin-releasing hormone immunoreactivity in the intermediolateral cell column of the rat spinal cord

21 January 2018

1 reference

Anatomical study of serotonergic innervation and 5-HT(1A) receptor in the human spinal cord

21 January 2018

1 reference

Origins of serotonergic projections to the spinal cord in rat: an immunocytochemical-retrograde transport study

21 January 2018

1 reference

Serotonin Reciprocally Regulates Melanocortin Neurons to Modulate Food Intake

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JNE.12287

1 reference

release_4ovu62f6qva3zlawtoswzf33yq

3 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4ovu62f6qva3zlawtoswzf33yq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference